Gastroenterology Clinical Trials | Norton Healthcare Louisville, Ky.

Gastroenterology Clinical Trials

Norton Healthcare is at the forefront of research for gastroenterology disorders. As principal investigators on numerous trials, our specialist physicians have access to innovative treatments.

See a full list of clinical trials offered at Norton Healthcare.

Learn more about participating in a clinical trial at Norton Healthcare.

Active Norton Healthcare gastroenterology clinical trials include:

Bowel Resection

A phase 2, multicenter, randomized, double-blind, placebo-controlled study of naldemedine in patients undergoing surgeries that include a bowel resection or bowel transection

Gastrointestinal Cancer

A Phase 3, Global, Multi-Center, Double-Blind, Randomized, Efficacy Study of IMAB362 Plus mFOLFOX6 Compared with Placebo Plus mFOLFOX6 as First-line Treatment of Subjects with Claudin (CLDN)18.2-Positive, HER2-Negative, Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal […]

Gastrointestinal Cancer

PANOVA 3: Pivotal, randomized, open-label study of Tumor Treating Fields (TTFields, 150kHz) concomitant with gemcitabine and nab-paclitaxel for frontline treatment of locally-advanced pancreatic adenocarcinoma

Gastrointestinal Cancer

A Phase 3, Interventional, Randomized, Multicenter, Open-Label Study of DCC-2618 vs Sunitinib in Patients with Advanced Gastrointestinal Stromal Tumors after Treatment with Imatinib

Gastrointestinal Cancer

A Phase 3, Randomized, Double-Blind Study of Pamrevlumab or Placebo in combination with Gemcitabine Plus Nab-paclitaxel as Neoadjuvant Treatment in Patients with Locally Advanced, Unresectable Pancreatic Cancer

Gastrointestinal Cancer

A Phase III Open-Label, Multi-Centre, Randomised Study Comparing NUC-1031 plus Cisplatin to Gemcitabine plus Cisplatin in Patients with Previously Untreated Locally Advanced or Metastatic Biliary Tract Cancer

Bowel Resection

A phase 2, multicenter, randomized, double-blind, placebo-controlled study of naldemedine in patients undergoing surgeries that include a bowel resection or bowel transection

Cancer

Evaluation of Biomarkers as a Predictor of Cancer and Healing

Cell Tumors

Examining patterns of use for the NanoKnife® Irreversible Electroporation Device in the real world: the NanoKnife Product Registry (OM1)

Cholangiocarcinoma

A Phase 3 Multicenter, Open-Label, Randomized, Controlled Study of Oral Infigratinib versus Gemcitabine with Cisplatin in Subjects with Advanced/Metastatic or Inoperable Cholangiocarcinoma with FGFR2 Gene Fusions/Translocations: The PROOF Trial

Hepatocellular Carcinoma (HCC)

A Phase 3 Double-blinded, Two-arm Study to Evaluate the Safety and Efficacy of Pembrolizumab (MK-3475) versus Placebo as Adjuvant Therapy in Participants with Hepatocellular Carcinoma and Complete Radiological Response after Surgical Resection or Local Ablation […]

Liver Disease

A Humanitarian Device Exemption Treatment Protocol of TheraSphere® For Treatment of Unresectable Primary or Secondary Liver Neoplasia

Pancreatic Adenocarcinoma

Immunotherapy and Irreversible Electroporation in the Treatment of Advanced Pancreatic Adenocarcinoma

Pancreatic Adenocarcinoma

Registry To Evaluate Effectiveness And Safety Of The NanoKnife System For The Ablation Of Stage 3 Pancreatic Adenocarcinoma: The Direct Registry For IRE Cancer Treatment

Pancreatic Adenocarcinoma

A Randomized, Multicenter, Controlled, Unblinded Study to Assess the Safety and Efficacy of the NanoKnife® System for the Ablation of Unresectable Stage 3 Pancreatic Adenocarcinoma

Pancreatic Cancer

Chemotherapy and Irreversible Electroporation in the Treatment of Advanced Pancreatic Adenocarcinoma

Pancreatic Insufficiency

Optimization of Exocrine Pancreatic Insufficiency in Pancreatic Adenocarcinoma Patients

Overall – 1234

Fort Knox area gets easier access to military veteran sports medicine physician

When sports medicine physician Scotty Newcomer, D.O., was offered a chance to treat soldiers from Fort Knox, he jumped at it. “I said, ‘Yeah, let’s do it,’” Dr. Newcomer said. Dr. Newcomer, an Air Force […]

Read Full Story

Lynn Hundley named American Heart Association Volunteer of the Year

The American Heart Association (AHA) has named Lynn Hundley, director of clinical effectiveness and stroke care at Norton Neuroscience Institute, as its 2020 Volunteer of the Year. Lynn hopes to be able to accept the […]

Read Full Story

On-site genomic testing at Norton Cancer Institute allows fast and precise treatment

Thanks to the Steven Vanover Foundation and other caring community supporters, Norton Cancer Institute now has specialized laboratory capabilities and equipment to perform on-site genomic testing. This highly specialized testing makes it possible to diagnose […]

Read Full Story

Thinking of going back to the gym? Ask these questions first

Working from home, staying safe at home or just not moving much? If you’re ready to start or resume a fitness routine, there are plenty of new considerations such as whether you need to wear […]

Read Full Story

Robot-assisted knee replacement surgery allows for greater precision

Orthopedic surgeon Joseph W. Greene, M.D., with Norton Orthopedic Institute, does hundreds of knee replacement surgeries every year. Now, he works alongside a robotic knee replacement surgical system that offers more precision, leading to a […]

Read Full Story

Search our entire site.

Schedule an Appointment

Select an appointment date and time from available spots listed below.